Arch Biopartners Inc. (OTCPK: ACHF.F)
Health Care · Life Sciences Tools & Services · CA
$0.62
+6.99% today · -16.7% 1Y
Arch Biopartners Inc. (OTCPK: ACHF.F) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $42.12M.
Over the last twelve months the share price has lost 16.7%, trading between 0.29 and 1.02.
Tweenvest scores Arch Biopartners Inc. across four factors: quality 8/100, value 55/100, growth 0/100. Its strongest factor is value.
ACHF.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.12M
- Revenue (TTM)
- $0.00
- P/E
- -20.60
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.61
- 52-week high
- $1.02
- 52-week low
- $0.29
- Avg volume (3M)
- —
- Shares outstanding
- 67.93M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Carna Biosciences, Inc.TSE: 4572 | $48.89M | ¥331.00 | -8.82% |
| hVIVO plcAIM: HVO | $48.20M | £0.05 | -12.50% |
| Chiome Bioscience Inc.TSE: 4583 | $44.59M | ¥89.00 | -1.11% |
| Eone Diagnomics Genome Center Co., Ltd.KOSDAQ: A245620 | $42.41M | ₩— | — |
| Cryosite LimitedASX: CTE | $41.79M | AU$1.22 | +1.67% |
| Harvard Bioscience, Inc.NasdaqCM: HBIO | $40.52M | $8.90 | +8.14% |
| ENCell Co., Ltd.KOSDAQ: A456070 | $38.66M | ₩4,675.00 | -3.11% |
| Macter International LimitedKASE: MACTER | $38.16M | PKRs230.33 | -1.08% |
Figures last refreshed Nov 8, 2026.